
Ledipasvir 90 mg + Sofosbuvir 400 mg (Myhep LVIR) is a combination antiviral medicine used to treat chronic hepatitis C virus (HCV) infection. It works by targeting different stages of the hepatitis C virus life cycle, helping stop viral replication and clear the infection. This treatment can provide high cure rates for suitable patients when taken exactly as prescribed.
| Generic name | Ledipasvir/Sofosbuvir |
| Strength | 90 mg + 400 mg |
| Manufacturer | MYLAN |
| Package size | 28 Tablets |
| Used for | Chronic hepatitis C virus (HCV) infection |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Ledipasvir is an NS5A inhibitor, while sofosbuvir is an NS5B polymerase inhibitor. Together, they block two essential proteins that the hepatitis C virus needs to multiply. This prevents the virus from replicating and allows the body to clear the infection during the prescribed course of treatment.